MoonLake Immunotherapeutics (NAS:MLTX)
$ 40.92 -1.05 (-2.5%) Market Cap: 2.57 Bil Enterprise Value: 2.10 Bil PE Ratio: 0 PB Ratio: 4.86 GF Score: 24/100

MoonLake Immunotherapeutics (MLTX) Stock Estimates Data

MoonLake Immunotherapeutics (MLTX) 12 Month Price Targets

MoonLake Immunotherapeutics (MLTX) Analyst Rating